Here, we established a model to describe the renal clearance of PAH using the in vitro CLint value obtained at initial rate (15 s) and parameter estimation of the REF value, thereby accounting for unknowns in the relevant scaling factors for OAT1 for IVIVE. Here, SLC22A6 is linked to pulmonary arterial hypertension.